A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for Candidemia and its consequences in nonneutropenic subjects. Rex J H, Pappas P G, Karschmer A W, et al for the National Institute for Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 2003 May 15; 36 (10): 1221-8.
Guardado en:
Autor principal: | Calvo A,Mario |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Chilena de Infectología
2003
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182003000300014 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
por: Jakub Suchodolski, et al.
Publicado: (2021) -
High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis
por: Julliana Ribeiro Alves Santos, et al.
Publicado: (2017) -
Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study
por: Nada WM, et al.
Publicado: (2017) -
Fluconazol profiláctico en prematuros
por: Coria De la H,Paulina
Publicado: (2007) -
COMPARATIVE EFFICACY OF ORAL FLUCONAZOLE AND ORAL ITRACONAZOLE IN PITYRIASIS VERSICOLOR
por: Muhammad Rizwan, et al.
Publicado: (2021)